GLP-1 receptor agonists work by stimulating GLP-1 receptors in the body, which leads to several beneficial effects: Increased insulin secretion: GLP-1 receptor agonists promote insulin release from the pancreas, helping to lower blood sugar levels Reduced glucagon secretion: These medications inhibit the release of glucagon, a hormone that increases blood sugar levels, thereby reducing glucose production Slowed gastric emptying: GLP-1 receptor agonists slow down the emptying of the stomach, leading to increased feelings of fullness and reduced appetite Additionally, tirzepatide, the active ingredient in Mounjaro works on GIP receptors
Maintenance To maintain long-term results, touch-up sessions every 612 months are often recommended, especially for hormone-sensitive areas
Iwaya, C
Many patients wonder whether taking both medications together amplifies resultsand clinical evidence suggests strategic combination therapy may offer meaningful benefits when prescribed appropriately
Pharmacies must follow state regulations, product labeling, and quality procedures for DTP delivery including temperature control, documentation, and patient instructions on immediate refrigeration
Avoid drinking on an empty stomach